Printer Friendly
The Free Library
14,635,740 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Antigenics to Present at UBS Global Generic and Specialty Pharmaceuticals Conference.


NEW YORK -- Antigenics Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
: AGEN) today announced that Garo H. Armen Garo H. Armen is chairman and chief executive officer of Antigenics Inc., the biotechnology company he cofounded with Pramod Srivastava in 1994. From mid-2002 through 2004, he was chairman of the board of directors for the biopharmaceutical company Elan Corporation plc. Dr. , PhD, the company's chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , will present at the UBS UBS Union Bank of Switzerland
UBS United Bible Societies
UBS United Blood Services
UBS United Buying Service
UBS Used Bookstore
UBS University Business Services
UBS Universal Building Society (UK)
UBS Ulaanbaatar Broadcasting System
 Global Generic and Specialty Pharmaceuticals Conference at the Grand Hyatt New York at 9:00 a.m. ET on Wednesday, May 9.

Dr. Armen will provide an overview of the company and its priority development programs, including Oncophage([R]) (vitespen) therapeutic cancer vaccine; QS-21[TM] vaccine adjuvant adjuvant /ad·ju·vant/ (aj?dbobr-vant) (a-joo´vant)
1. assisting or aiding.

2. a substance that aids another, such as an auxiliary remedy.

3.
; AG-707 therapeutic vaccine for genital herpes infection; and Aroplatin[TM] platinum agent for cancers.

The audio portion of the presentation will be webcast live and available subsequently by replay on the UBS website at: http://www.ibb.ubs.com (follow the Conferences link). The replay of the webcast will begin approximately three hours after the live presentation and will be available for approximately 30 days. The link to the audio replay and presentation slides will also be available on the Antigenics website, www.antigenics.com.

Antigenics is a biotechnology company working to develop treatments for cancers and infectious diseases.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:May 2, 2007
Words:169
Previous Article:AAON, Inc. First Quarter 2007 Results Call.(Financial report)
Next Article:Company-Owned Operations ("Captives") in India Are Accelerating Despite Contrary Opinions, Says Everest Research Institute.
Topics:



Related Articles
Geron Corporation to Present at UBS Global Specialty Pharmaceuticals Conference.
POZEN To Present at the 2007 UBS Global Generic and Specialty Pharmaceuticals Conference.
Lannett Company to Present at UBS Global Generic and Specialty Pharmacueticals Conference.
Tongjitang Chinese Medicines Company to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference.
Unigene to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference on May 8, 2007.
Hi-Tech Pharmacal to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference.
Noven to Present at UBS Global Generic and Specialty Pharmaceuticals Conference.
Beijing Med-Pharm Corporation to Present at the UBS Global Generic and Specialty Pharmaceuticals Conference.
Geron Corporation to Present at UBS Global Generic & Specialty Pharmaceuticals Conference.
Oncophage(R) Cancer Vaccine Significantly Prolongs Recurrence-Free Survival by 45 Percent in Patients With Intermediate-Risk Kidney Cancer.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles